Drug
hydroxyethyl starch (HES 130/0.6)
hydroxyethyl starch (HES 130/0.6) is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
completed267%
not_yet_recruiting133%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable
Mild ANH on Pre-bypass Coagulation Function During Cardiac Surgery
NCT06664320
completednot_applicable
Acute Normovolemic Hemodilution on ROTEM in Cardiac Surgery
NCT02502448
completed
Acute Normovolemic Hemodilution on Serum-creatinine Concentration in Cardiac Surgery
NCT02831270
Clinical Trials (3)
Showing 3 of 3 trials
NCT06664320Not Applicable
Mild ANH on Pre-bypass Coagulation Function During Cardiac Surgery
NCT02502448Not Applicable
Acute Normovolemic Hemodilution on ROTEM in Cardiac Surgery
NCT02831270
Acute Normovolemic Hemodilution on Serum-creatinine Concentration in Cardiac Surgery
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3